placebo ointment (vehicle)

DRUG3 trials

Sponsors

Pfizer

Conditions

Dermatitis, AtopicPsoriasisPsoriasis Vulgaris

Phase 2

Tofacitinib Ointment For Chronic Plaque Psoriasis

CompletedNCT01831466

PfizerPsoriasis, Psoriasis Vulgaris

Start: 2013-05-31End: 2014-09-30Updated: 2015-11-25

Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)

CompletedNCT02001181

PfizerDermatitis, Atopic

Start: 2013-12-31End: 2014-09-30Updated: 2015-10-15

Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis

CompletedNCT03233529

PfizerDermatitis, Atopic

Start: 2017-07-31End: 2018-05-04Updated: 2019-08-13

Related Papers

Systemic Tofacitinib Concentrations in Adult Patients With Atopic Dermatitis Treated With 2% Tofacitinib Ointment and Application to Pediatric Study Planning

The Journal of Clinical Pharmacology2018-12-1736 citations

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial

BMC Dermatology2016-10-0398 citations

Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.

2016-09-24277 citations